KEYTRUDA

Google image searchProduct monograph

Active ingredient

pembrolizumab, 25 MG/ML

DIN: 02456869

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: FOR I.V. INFUSION. 4 ML SINGLE USE VIAL.

Schedule: Prescription / Schedule D

Company: MERCK CANADA INC

Date: 13-JUL-2017

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
• L01FF02 — PEMBROLIZUMAB (ATC/DDD)

Reference brand drug: Keytruda

External Links for Keytruda

Search on Google

• Keytruda side effects
• Keytruda dosage
• pembrolizumab side effects
• pembrolizumab dosage

Merck Canada Inc

Go to Merck website to see drug product details. Sometimes you can find keytruda photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.